These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Flecainide versus quinidine: results of a multicenter trial. Hodges M; Salerno DM; Granrud G Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770 [TBL] [Abstract][Full Text] [Related]
7. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity. Hoffmann A; Wenk M; Follath F Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634 [TBL] [Abstract][Full Text] [Related]
8. Flecainide: a new agent for the treatment of ventricular arrhythmias. Grubb BP; Tilley-Gray B Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958 [TBL] [Abstract][Full Text] [Related]
9. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461 [No Abstract] [Full Text] [Related]
10. Refractory ventricular tachycardia with flecainide. Wynn J; Fingerhood M; Keefe D; Maza S; Miura D; Somberg JC Am Heart J; 1986 Jul; 112(1):174-5. PubMed ID: 3728275 [No Abstract] [Full Text] [Related]
11. Flecainide-induced aggravation of ventricular tachycardia. Hohnloser S; Zeiher A; Hust MH; Wollschläger H; Just H Clin Cardiol; 1983 Mar; 6(3):130-5. PubMed ID: 6851274 [TBL] [Abstract][Full Text] [Related]
12. The proarrhythmic effects of flecainide. Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779 [TBL] [Abstract][Full Text] [Related]
13. A proposal for the clinical use of flecainide. Anderson JL; Stewart JR; Crevey BJ Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767 [TBL] [Abstract][Full Text] [Related]
14. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia]. Aliot E; Baille N; Zannad F; Gilgenkrantz JM Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988 [No Abstract] [Full Text] [Related]
15. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients. Salerno DM; Hodges M; Granrud G; Sharkey P Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575 [TBL] [Abstract][Full Text] [Related]
17. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883 [TBL] [Abstract][Full Text] [Related]
18. Flecainide: a new class Ic antidysrhythmic. Smith GH Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429 [TBL] [Abstract][Full Text] [Related]
19. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up. Anderson JL Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820 [TBL] [Abstract][Full Text] [Related]
20. Flecainide: a new antiarrhythmic drug. Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388 [No Abstract] [Full Text] [Related] [Next] [New Search]